Exodus Point Capital Management, LP Beam Therapeutics Inc. Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 166,055 shares of BEAM stock, worth $4.48 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
166,055Holding current value
$4.48 Million% of portfolio
0.02%Shares
9 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$270 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$262 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$239 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$206 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$128 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.9B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...